All Facilities , From 2026-03-30 - 2026-04-13
AMR INDICATOR 3 :: Drug Resistance
n = 328 Number of Isolates
All Specimens All Organisms
n = 328 Number of Isolates
All Specimens All Organisms
| Anntibiotic | Total Tested | Number Susceptibility | % Susceptibility |
|---|---|---|---|
| Teicoplanin | 21 | 20 | 95.2 |
| Moxifloxacin | 14 | 13 | 92.9 |
| Meropenem | 166 | 149 | 89.8 |
| Rifampin | 18 | 16 | 88.9 |
| Amikacin | 128 | 108 | 84.4 |
| Micafungin | 6 | 5 | 83.3 |
| Ertapenem | 6 | 5 | 83.3 |
| Amoxicillin/Clavulanic acid | 6 | 5 | 83.3 |
| Tobramycin | 6 | 5 | 83.3 |
| Linezolid | 49 | 40 | 81.6 |
| Nitrofurantoin | 98 | 79 | 80.6 |
| Imipenem | 114 | 90 | 78.9 |
| Vancomycin | 75 | 59 | 78.7 |
| Clindamycin | 71 | 50 | 70.4 |
| Flucytosine | 6 | 4 | 66.7 |
| Levofloxacin | 82 | 53 | 64.6 |
| Piperacillin/Tazobactam | 176 | 113 | 64.2 |
| Gentamicin | 248 | 137 | 55.2 |
| Trimethoprim | 17 | 9 | 52.9 |
| Chloramphenicol | 78 | 39 | 50.0 |
| Fluconazole | 6 | 3 | 50.0 |
| Cefoxitin | 62 | 30 | 48.4 |
| Doxycycline | 25 | 12 | 48.0 |
| Ampicillin/ Sulbactam | 53 | 25 | 47.2 |
| Aztreonam | 46 | 21 | 45.7 |
| Nalidixic acid | 32 | 14 | 43.8 |
| Azithromycin | 14 | 6 | 42.9 |
| Ciprofloxacin | 265 | 110 | 41.5 |
| Cefepime | 112 | 45 | 40.2 |
| Ceftazidime | 186 | 71 | 38.2 |
| Tetracycline | 97 | 37 | 38.1 |
| Amoxicillin/ Clavulanic acid | 114 | 40 | 35.1 |
| Erythromycin | 76 | 25 | 32.9 |
| Penicillin G | 35 | 10 | 28.6 |
| Cefotaxime | 97 | 27 | 27.8 |
| Trimethoprim/Sulfamethoxazole | 208 | 57 | 27.4 |
| Piperacillin | 11 | 3 | 27.3 |
| Ceftriaxone | 169 | 36 | 21.3 |
| Cefuroxime | 113 | 24 | 21.2 |
| Ampicillin | 93 | 12 | 12.9 |
| Oxacillin | 9 | 1 | 11.1 |
| Voriconazole | 6 | 6 | 100.0 |
| Caspofungin | 5 | 5 | 100.0 |
| Augmentin(AMC) | 1 | 1 | 100.0 |
| Tigecycline | 1 | 1 | 100.0 |
| fosfomycin | 2 | 2 | 100.0 |